BANK OF AMERICA CORP /DE/ - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 68 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$10,217
+44.3%
35,230
+123.4%
0.00%
Q4 2022$7,081
+18.0%
15,770
+35.1%
0.00%
Q3 2022$6,000
+50.0%
11,676
+59.9%
0.00%
Q2 2022$4,000
-90.2%
7,301
-59.5%
0.00%
Q1 2022$41,000
-72.1%
18,005
-42.0%
0.00%
Q4 2021$147,000
-27.9%
31,067
+21.2%
0.00%
Q3 2021$204,000
+44.7%
25,639
+26.8%
0.00%
Q2 2021$141,000
-55.1%
20,216
-49.1%
0.00%
Q1 2021$314,000
+196.2%
39,690
+193.6%
0.00%
Q4 2020$106,000
-69.8%
13,517
-72.7%
0.00%
Q3 2020$351,000
+96.1%
49,490
+155.9%
0.00%
Q2 2020$179,000
+184.1%
19,337
+44.0%
0.00%
Q1 2020$63,000
-67.0%
13,430
-46.4%
0.00%
Q4 2019$191,000
-10.7%
25,041
-10.1%
0.00%
Q3 2019$214,000
+17.6%
27,865
+5.1%
0.00%
Q2 2019$182,000
+64.0%
26,510
+93.7%
0.00%
Q1 2019$111,000
-13.3%
13,688
-20.2%
0.00%
Q4 2018$128,000
+212.2%
17,145
+299.9%
0.00%
Q3 2018$41,000
+32.3%
4,287
+49.4%
0.00%
Q2 2018$31,000
-58.1%
2,870
-61.4%
0.00%
Q1 2018$74,000
+94.7%
7,444
+6.3%
0.00%
Q4 2017$38,000
+8.6%
7,0000.0%0.00%
Q3 2017$35,000
+1066.7%
7,000
+1473.0%
0.00%
Q3 2016$3,000
-25.0%
445
-47.3%
0.00%
Q2 2016$4,0008450.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Yu Fan 112,044$258,0003.49%
Aisling Capital Management LP 1,691,151$3,890,0002.10%
Sio Capital Management, LLC 871,101$2,004,0000.66%
Bain Capital Life Sciences Investors, LLC 2,847,689$6,550,0000.64%
Samsara BioCapital, LLC 883,720$2,033,0000.51%
Ghost Tree Capital, LLC 686,599$1,579,0000.34%
Nantahala Capital Management 3,200,593$7,361,0000.33%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$565,0000.29%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,059,894$9,338,0000.28%
Lion Point Capital, LP 300,000$690,0000.16%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders